Table 4 Distribution of study population according to the indications of allopurinol prescription
From: The pattern of allopurinol prescription in a university hospital practice
Indication | Frequency | Percent | Valid percent | Cumulative percent |
|---|---|---|---|---|
None | 32 | 7.5% | 7.5% | 7.5% |
Gouty arthritis (confirmed) | 40 | 9.4% | 9.4% | 16.9% |
Gouty arthritis (not confirmed) | 50 | 11.7% | 11.7% | 28.6% |
Marked hyperuricemia (13 male, 10 female) | 19 | 4.4% | 4.5% | 33.1% |
Insignificant hyperuricemia (less than 13 males, 10 females) | 208 | 48.7% | 48.8% | 81.9% |
Kidney stone (was not analyzed) | 55 | 12.9% | 12.9% | 94.8% |
Uric acid stone | 6 | 1.4% | 1.4% | 96.2% |
Recurrent calcium oxalate stone | 8 | 1.9% | 1.9% | 98.1% |
Hemolysis (regardless of the cause) | 2 | 0.5% | 0.5% | 98.6% |
Genetic defects | 3 | 0.7% | 0.7% | 99.3% |
Malignancy | 3 | 0.7% | 0.7% | 100.0% |
Total | 426 | 99.8% | 100.0% | Â |
Total | 427 | 100.0% | Â | Â |